In addition, GRPR antagonism by RC-3095, alone or combined with temozolomide, significantly reduced the growth of C6 gliomas both in vitro and in vivo, with the combined administration of TMZ and RC-3095 being the most effective treatment (Figure 5; de Oliveira et al., 2009). Here, GRPR is linked to central nervous system cancer.